湘财证券：维持线下药店业“增持”评级 医疗耗材领域把握出海等三条主线

Group 1 - The core viewpoint of the article emphasizes maintaining an "overweight" rating for offline pharmacies, focusing on companies with significant advantages in compliance, supply chain, and digital management, as well as those that can successfully integrate and enhance the efficiency of acquired stores [1] - The medical consumables industry also maintains an "overweight" rating, with three main lines of focus: performance reversal, increased penetration rates, and international expansion [1] - Recent pressures on the medical consumables sector due to anti-corruption measures and centralized procurement have affected performance, but long-term fundamentals for domestic high-value consumables companies remain positive due to factors like aging population, increased penetration of innovative procedures, and rising domestic production rates [1] Group 2 - The Chinese chain pharmacy industry has transitioned from a phase of growth driven by the expansion of store numbers to a high-quality development era focused on operational efficiency, service value, and ecosystem construction [1] - Under policy guidance, the industry is moving towards supply-side clearing and increased concentration, where well-managed leading chain brands are expected to gather resources and optimize operations, leading to an early recovery in market conditions [1]